Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Daiichi Sankyo
Teva
McKinsey
Colorcon
Farmers Insurance
Healthtrust
Johnson and Johnson

Generated: May 22, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Claravis

« Back to Dashboard

Bulk Pharmaceutical API Sources for Claravis

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ➤ Sign Up R3255_SIGMA ➤ Sign Up
NovoSeek ➤ Sign Up 5282379 ➤ Sign Up
MolPort ➤ Sign Up MolPort-003-666-394 ➤ Sign Up
NIH Clinical Collection ➤ Sign Up SAM002548955 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Baxter
Dow
Federal Trade Commission
Accenture
Mallinckrodt
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.